Cargando…

Decreased Gene Expressions of Insulin Signal Molecules in Canine Hyperadrenocorticism

Hyperadrenocorticism (HAC) is a common endocrine disorder in dogs, in which excess glucocorticoid causes insulin resistance. Disturbance of insulin action may be caused by multiple factors, including transcriptional modulation of insulin signal molecules which lie downstream of insulin binding to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	NOZAWA, Satoshi, ODA, Hitomi, AKIYAMA, Ran, UEDA, Kaori, SAEKI, Kaori, SHONO, Saori, MARUYAMA, Natsuki, MURATA, Atsuki, TAZAKI, Hiroyuki, MORI, Akihiro, MOMOTA, Yutaka, AZAKAMI, Daigo, SAKO, Toshinori, ISHIOKA, Katsumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Veterinary Science 2014
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155204/ https://www.ncbi.nlm.nih.gov/pubmed/24829079 http://dx.doi.org/10.1292/jvms.14-0033

Ejemplares similares

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Analyses of a satiety factor NUCB2/nesfatin-1; gene expressions and modulation by different dietary components in dogs
por: NOZAWA, Satoshi, et al.
Publicado: (2015)

Genetic variants of the unsaturated fatty acid receptor GPR120 relating to obesity in dogs
por: MIYABE, Masahiro, et al.
Publicado: (2015)

Primary T-cell high-grade lymphoma of the feline uterus
por: AZAKAMI, Daigo, et al.
Publicado: (2016)

Successful treatment of feline hyperadrenocorticism with pituitary macroadenoma using radiation therapy: a case study
por: YAYOSHI, Naoko, et al.
Publicado: (2022)

Evaluation of newly developed veterinary portable blood glucose meter with hematocrit correction in dogs and cats
por: MORI, Akihiro, et al.
Publicado: (2017)

Proliferative and necrotizing otitis externa in a kitten: successful treatment with intralesional and topical corticosteroid therapy
por: MOMOTA, Yutaka, et al.
Publicado: (2016)

Preliminary Study Characterizing the Use of Sitagliptin for Glycemic Control in Healthy Beagle Dogs with Normal Gluco-Homeostasis
por: ODA, Hitomi, et al.
Publicado: (2014)

Time-action profiles of insulin degludec in healthy dogs and its effects on glycemic control in diabetic dogs
por: ODA, Hitomi, et al.
Publicado: (2018)

Successful treatment of refractory demodicosis and transient papules with a single dose of fluralaner in a dog with uncontrolled severe endocrine disease
por: MORITA, Tatsushi, et al.
Publicado: (2018)

The Silicon Concentration in Cat Urine and Its Relationship with Other Elements
por: TAKAHASHI, Fumihito, et al.
Publicado: (2013)

Utility of a corticotropin‐releasing hormone test to differentiate pituitary‐dependent hyperadrenocorticism from cortisol‐producing adrenal tumors in dogs
por: Tanaka, Sachiyo, et al.
Publicado: (2021)

Effect of an Insulation Device in Preventing Hypothermia during Magnetic Resonance Imaging Examinations for Dogs and Cats under General Anesthesia
por: Onozawa, Eri, et al.
Publicado: (2021)

Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism
por: Frank, L.A., et al.
Publicado: (2014)

The effect of Insulin Degludec on glycemic control in diabetic cats over a 12-month period
por: ODA, Hitomi, et al.
Publicado: (2020)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
por: Teshima, Takahiro, et al.
Publicado: (2016)

Metabolite profiling in sphere-forming cells from canine mammary adenocarcinoma cell lines using gas chromatography-mass spectrometry
por: MICHISHITA, Masaki, et al.
Publicado: (2019)

Effect of Hot Water Bottles on Body Temperature during Magnetic Resonance Imaging in Dogs under General Anesthesia: A Retrospective Study
por: Shimizu, Yuki, et al.
Publicado: (2022)

Novel canine isocitrate dehydrogenase 1 mutation Y208C attenuates dimerization ability
por: Kawakami, Shota, et al.
Publicado: (2020)

Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid
por: Huang, Hui-Pi, et al.
Publicado: (2013)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Patterns of the low‐dose dexamethasone suppression test in canine hyperadrenocorticism revisited
por: Zeugswetter, Florian K., et al.
Publicado: (2021)

Long-term management and postmortem examination in a diabetic cat with acromegaly treated with two courses of radiation therapy
por: SAWADA, Harumi, et al.
Publicado: (2018)

A canine case of splenic hemangiosarcoma complicated with infectious splenic abscess
por: Oyamada, Tomohiro, et al.
Publicado: (2022)

Comparison of the effects of four commercially available prescription diet regimens on the fecal microbiome in healthy dogs
por: MORI, Akihiro, et al.
Publicado: (2019)

Comparison of cholesterol levels among lipoprotein fractions separated by anion-exchange high-performance liquid chromatography in periparturient Holstein–Friesian dairy cows
por: TAKAHASHI, Tomoya, et al.
Publicado: (2020)

In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines
por: Maeda, Marika, et al.
Publicado: (2022)

Trismus due to myotonia associated with hyperadrenocorticism in a dog
por: YOKOTA, Shunya, et al.
Publicado: (2023)

Canine Pancreatic‐Specific Lipase Concentrations in Clinically Healthy Dogs and Dogs with Naturally Occurring Hyperadrenocorticism
por: Mawby, D.I., et al.
Publicado: (2014)

Molecular Characterization of the Cytidine Monophosphate-N-Acetylneuraminic Acid Hydroxylase (CMAH) Gene Associated with the Feline AB Blood Group System
por: Omi, Toshinori, et al.
Publicado: (2016)

Relationship between anti-insulin antibody production and severe insulin resistance in a diabetic cat
por: KOMIYA, Takumi, et al.
Publicado: (2021)

Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation
por: KAWAKAMI, Shota, et al.
Publicado: (2017)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Quantitative CT assessment of bone mineral density in dogs with hyperadrenocorticism
por: Lee, Donghoon, et al.
Publicado: (2015)

Ultrasonographic evaluation of skin thickness in small breed dogs with hyperadrenocorticism
por: Heo, Seonghun, et al.
Publicado: (2018)

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Suspected spontaneous hyperadrenocorticism in a young experimental beagle dog
por: Obara, Ryo D., et al.
Publicado: (2021)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Skin fragility in a cat presenting with pituitary-dependent hyperadrenocorticism
por: Hardy, Lorna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ufbpoa6p8kbjvjbdj172kbbnvj